NCT02956239Completed
Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries
Source: ClinicalTrials.gov · Last updated 8 Jul 2024
Brief summary (registry, in English)
This project develops, tests and produces a lightweight, cordless, battery driven and rechargeable hand-held device for treating cervical precancer (Liger Thermal Coagulator). The study evaluates its effectiveness compared to the current standard treatment (cryocautery) when used as part of a screen and treat programme using Visual Inspection with Acetic acid (VIA) in Sub Saharan Africa.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 3124 (actual)
- First submitted
- 6 Sept 2016
- Start date
- 1 Aug 2017
- Primary completion date
- 16 Feb 2022
- Lead sponsor
- International Agency for Research on Cancer
- Diseases
- Cervical cancer
- NCT number
- NCT02956239
What you commit to
- Study type: Interventional
- Participants enrolled: 3124
- From 1 Aug 2017 to the primary completion date, 16 Feb 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnancy
- Not voluntarily willing to participate
Who the study is looking for
- Positive on VIA test for cervical cancer screening
- Eligible for ablative treatment
Age in the registry: 25 years to 49 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UNC Global Project Zambia Coordinator of this site? Confirm its status | Lusaka | Zambia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.